Covid-19: Pfizer’s vaccine shows 90% efficiency

Source : 112 Ukraine

Trump says the vaccine is coming soon
23:58, 9 November 2020


A front-runner coronavirus vaccine developed by drug giant Pfizer and German biotechnology firm BioNTech has shown 90% efficiency in the interim results of the third phase of clinical trials. This was reported by the press service of Pfizer.

Their vaccine has been tested on 43,500 people in six countries and no safety concerns have been raised.

Related: Ukraine not to test American vaccine against Covid-19, - official

The companies plan to apply for emergency approval to use the vaccine by the end of the month.

No vaccine has gone from the drawing board to being proven highly effective in such a short period of time.

Related: Hope: How long to wait for coronavirus vaccine?

Donald Trump, who had called Pfizer chief executive Albert Bourla to ask about the vaccine and previously accused regulators of a "political hit job" for slowing down a vaccine, celebrated the news.

As we reported earlier, head of the Health Ministry Maksym Stepanov stated about the possibility of accession of Ukraine to the development of the vaccine held by British Company AstraZeneca.

“The Health Ministry is in constant connection with AstraZeneca Company that along with Oxford University develops the vaccine against the coronavirus; its production might be started soon. We also consider the possibility to include the Ukrainian capacities into the production of this vaccine,” Stepanov said. 

Related: Israel orders 1.5 million doses of Russian coronavirus vaccine

Система Orphus

If you find an error, highlight the desired text and press Ctrl + Enter, to tell about it

see more